PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China.\', \'The NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, China CDC, 102206, Beijing, China. tanwj@ivdc.chinacdc.cn.\', \'Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China. pengxiaozhong@pumc.edu.cn.\', \'Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China. imbcams.lq@gmail.com.\', \'Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, 650118, Kunming, China. xzp@imbcams.com.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41392-022-00920-4
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 35217639
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Three doses of prototypic SARS-CoV-2 inactivated vaccine induce cross-protection against its variants of concern.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all